\
&
Contact us
\
&
Contact us
This was 11 months ago
LocationBrussels
The Belgian Horizon Europe National Contact Points (NCPs) are organising a training session on 'Impact in Horizon Europe', targetting (potential) applicants.
During this session, participants will :
Our target audience are stakeholders located in Belgium who are planning to or interested in participating in Horizon Europe actions. We encourage applicants with less experience to participate in this training session.
Registration is open! More detailed information and registration on this webpage.
Please note that places for this on-site event are limited, participants will be accepted on a first come first served basis and the organisers reserve the right to decline any registration.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
